Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 312-319

  Haddad, François ^a   Fisher, Patrick ^b   Pham, Michael ^a   Berry, Gerald ^a   Weisshaar, Dana ^c   Kuppahally, Suman ^a   Vrtovec, Bojan ^d   Deuse, Tobias ^a   Virani, Sean ^a   Fearon, William ^a   Valantine, Hannah ^a   Hunt, Sharon ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c Northern California   (United States)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; DRUG USE; EVENT FREE SURVIVAL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMICALLY COMPROMISING REJECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYOCARDITIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MYOCARDITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 62949162497     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.12.023     Document Type: Article

References (36)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
2. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 16 (1997) 813-821
3. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8 (1989) 430-443
4. Patel V.S., Lim M., Massin E.K., et al. Sudden cardiac death in cardiac transplant recipients. Circulation 94 (1996) II-273-7
5. de Groote P., Millaire A., Foucher-Hossein C., Nugue O., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 32 (1998) 948-954
6. Di Salvo T.G., Mathier M., Semigran M.J., et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 25 (1995) 1143-1153
7. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
8. Reed E.F., Demetris A.J., Hammond E., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
9. Venkataraman R., and Kellum J.A. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med 22 (2007) 187-193
10. Hiemann N.E., Wellnhofer E., Knosalla C., et al. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation 116 (2007) 1274-1282
11. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58-69
12. Haddad F., Doyle R., Murphy D.J., et al. Right ventricular function in cardiovascular disease. Part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117 (2008) 1717-1731
13. Polak J.F., Holman B.L., Wynne J., et al. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 2 (1983) 217-224
14. de Groote P., Millaire A., Foucher-Hossein C., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 32 (1998) 948-954
15. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 183-188
16. Mendes L.A., Dec G.W., Picard M.H., et al. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128 (1994) 301-307
17. Michaels P.J., Fishbein M.C., and Colvin R.B. Humoral rejection of human organ transplants. Springer Semin Immunopathol 25 (2003) 119-140
18. Crespo-Leiro M.G., Veiga-Barreiro A., Domenech N., et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 5 (2005) 2560-2564
19. Grauhan O., Knosalla C., Ewert R., et al. Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 20 (2001) 316-321
20. Veiga B.A., Crespo L.M., Domenech G.N., et al. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management. Transplant Proc 36 (2004) 778-779
21. Aranda Jr. J.M., Scornik J.C., Normann S.J., et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73 (2002) 907-910
22. Garrett Jr. H.E., Groshart K., Duvall-Seaman D., et al. Treatment of humoral rejection with rituximab. Ann Thorac Surg 74 (2002) 1240-1242
23. Lehrich R.W., Rocha P.N., Reinsmoen N., et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 66 (2005) 350-358
24. Colovai A.I., Vasilescu E.R., Foca-Rodi A., et al. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies. Hum Immunol 66 (2005) 501-512
25. Kirklin J.K., Brown R.N., Huang S.T., et al. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 25 (2006) 283-288
26. Costanzo-Nordin M.R., Heroux A.L., Radvany R., et al. Role of humoral immunity in acute cardiac allograft dysfunction. J Heart Lung Transplant 12 suppl (1993) S143-S146
27. Itescu S., Tung T.C., Burke E.M., et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98 (1998) 786-793
28. Rose E.A., Smith C.R., Petrossian G.A., et al. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 106 (1989) 203-207
29. Rose E.A., Pepino P., Barr M.L., et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 11 suppl (1992) S120-S123
30. Tambur A.R., Bray R.A., Takemoto S.K., et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 70 (2000) 1055-1059
31. Tambur A.R., Winkel E., Heroux A., et al. Flow panel reactive antibody monitoring following heart transplantation. Transplant Proc 33 (2001) 3295-3297
32. Kobashigawa J.A., Starling R.C., Mehra M.R., et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant 25 (2006) 1063-1069
33. Marelli D., Laks H., Patel B., et al. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 22 (2003) 1091-1097
34. Russo M.J., Chen J.M., Hong K.N., et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 114 (2006) 2280-2287
35. Fearon W.F., Hirohata A., Nakamura M., et al. Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. J Heart Lung Transplant 25 (2006) 765-771
36. Vaughan T.B., and Bell D.S. Diabetic cardiomyopathy. Heart Fail Clin 2 (2006) 71-80